Kiltearn Partners LLP Medtronic PLC Transaction History

Kiltearn Partners LLP

$517 Million
Q1 2025

A detailed history of Kiltearn Partners LLP transactions in Medtronic PLC stock. As of the latest transaction made, Kiltearn Partners LLP holds 251,561 shares of MDT stock, worth $22.5 Million. This represents 4.37% of its overall portfolio holdings.

Number of Shares

251,561

Previous 296,261 15.09%

Holding current value

$22.5 Million

Previous $23.7 Million 4.48%

% of portfolio

4.37%

Previous 4.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$79.84 - $94.5 $3.57 Million - $4.22 Million	-44,700 Reduced 15.09%	251,561 $22.6 Million
Q4 2024 Feb 12, 2025	SELL	$79.61 - $92.24 $2.52 Million - $2.91 Million	-31,600 Reduced 9.64%	296,261 $23.7 Million
Q3 2024 Nov 13, 2024	SELL	$76.84 - $91.03 $2.45 Million - $2.9 Million	-31,900 Reduced 8.87%	327,861 $29.5 Million
Q2 2024 Aug 14, 2024	BUY	$78.71 - $87.02 $2.04 Million - $2.25 Million	25,900 Added 7.76%	359,761 $28.3 Million
Q1 2024 May 15, 2024	SELL	$82.84 - $88.09 $5.15 Million - $5.48 Million	-62,200 Reduced 15.7%	333,861 $29.1 Million
Q4 2023 Feb 13, 2024	BUY	$69.43 - $83.43 $10.8 Million - $12.9 Million	154,961 Added 64.27%	396,061 $32.6 Million
Q3 2023 Nov 13, 2023	SELL	$78.22 - $90.4 $657,048 - $759,360	-8,400 Reduced 3.37%	241,100 $18.9 Million
Q2 2023 Aug 10, 2023	SELL	$79.47 - $91.38 $596,025 - $685,350	-7,500 Reduced 2.92%	249,500 $22 Million
Q1 2023 May 15, 2023	BUY	$76.72 - $87.58 $4.72 Million - $5.39 Million	61,500 Added 31.46%	257,000 $20.7 Million
Q4 2022 Feb 08, 2023	BUY	$76.18 - $87.74 $14.9 Million - $17.2 Million	195,500 New	195,500 $15.2 Million

Others Institutions Holding MDT

# of Institutions

2,436

Shares Held

1.05B

Call Options Held

10.3M

Put Options Held

9.58M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $119B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiltearn Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Kiltearn Partners LLP with notifications on news.

Account

Kiltearn Partners LLP Medtronic PLC Transaction History